Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CRISABOROLE, with a corresponding US DMF Number 33278.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 01, 2021, and payment made on February 18, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II